Novavax（NASDAQ:NVAX）公布的季度亏损为每股$(1.23)，高于分析师一致预期的$(1.32)，超过预期6.82%。与去年同期每股亏损$(5.41)相比，这增加了77.26%。公司公布的季度销售额为$6.8216亿，低于分析师一致预期的$6.8494亿，低于预期0.41%。与去年同期$9.8371亿的销售额相比，下降了30.65%。
以上内容来自Benzinga Earnings专栏，原文如下：
Novavax (NASDAQ:NVAX) reported quarterly losses of $(1.23) per share which beat the analyst consensus estimate of $(1.32) by 6.82 percent. This is a 77.26 percent increase over losses of $(5.41) per share from the same period last year. The company reported quarterly sales of $682.16 million which missed the analyst consensus estimate of $684.94 million by 0.41 percent. This is a 30.65 percent decrease over sales of $983.71 million the same period last year.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。